Immunogenic cell death (ICD) is a unique mode of cell death, which can release
immunogenic damage‐associated molecular patterns (DAMPs) and tumor‐associated …

Over the past decade, colorectal cancer has reported a higher incidence in younger adults
and a lower mortality rate. Recently, the influence of the intestinal flora in the initiation …

Lysosome-mediated autophagy and caspase-dependent apoptosis are dynamic processes
that maintain cellular homeostasis, ensuring cell health and functionality. The intricate …

The presence of bacteria in tumor results in chemotherapeutic drug resistance and weakens
the immune response in colorectal cancer. To overcome bacterium‐induced …

CRISPR-Cas9 is a central focus of the emerging field of gene editing and photodynamic
therapy (PDT) is a clinical-stage ablation modality combining photosensitizers with light …

Background Immunogenic cell death (ICD) is a specific form of regulated cell death induced
by a variety of stressors. During ICD, the dying cancer cells release damage-associated …

Immunotherapy has emerged as a promising therapeutic strategy for cancer therapy.
However, the therapeutic efficacy has been distracted due to poor immunogenicity and …

Introduction Colorectal cancer (CRC) is the second most lethal malignancy worldwide.
Immune checkpoint inhibitors (ICIs) benefit only 15% of patients with mismatch repair …

Background In recent studies of cancer therapies, chemodrugs have attracted interest,
acting not only as traditional chemotherapeutic agents but also as anticancer immune …

Although immune checkpoint inhibitors (anti-PD-1 antibody, anti-PD-L1 antibody, and anti-
CTLA-4 antibody) have displayed considerable success in the treatment of malignant …